Higher levels of vascular endothelial growth factor (VEGF), acting on stimulating vascular endothelial cell growth and inducing vascular proliferation, were observed in non-alcoholic steatohepatitis (NASH) patients and non-alcoholic fatty liver (NAFL) patients than in control individuals [33]. Here, VEGFA is linked to metabolic dysfunction-associated steatohepatitis.